Introduction {#sec1}
============

In 2014 cervical cancer was the sixth most common gynaecological cancer diagnosed, seventh in terms of mortality among malignant tumours in Poland \[[@cit0001]\], and ranks fourth for both incidence and mortality worldwide \[[@cit0002]\]. External beam radiotherapy is one of the treatment options of this cancer and is more commonly used as either an independent method of treatment or supplementary to chemotherapy or surgery. Appropriate determination of the primary tumour boundaries in the treatment planning system plays a pivotal role not only in minimising the dose to the surrounding organs at risks, but also in minimising the risk of recurrence \[[@cit0003]\].

Metabolic tumour volume (MTV) assessed by PET/CT imaging using ^18^F-fluorodeoxyglucose (^18^F-FDG), a fluorine-radiolabelled glucose analogue, helps to assess the size of the biologically active tumour \[[@cit0004]\]. Based on Otto Warburg's observation of increased glucose utilisation in tumour cells \[[@cit0004]\], the radiopharmaceuticals, which are captured similarly to glucose, e.g. ^18^F-FDG, can be used in the imaging of cancerous tumours \[[@cit0005], [@cit0006]\]. The algorithm used to evaluate MTV in PET/CT can be based on: visual assessment, fixed maximum standardized uptake value (SUV~max~), or the threshold method based on the percentage of SUV~max~ \[[@cit0007]\].

The aim of the study was to assess the effect of different segmentation methods on primary metabolic tumour volume assessed in a ^18^F-FDG-PET/CT study in patients with cervical cancer.

Material and methods {#sec2}
====================

A retrospective analysis was performed on 30 newly diagnosed patients with cervical cancer (mean age: 55 ±11 years, range: 82--28 years), admitted to the Department of Radiotherapy and Gynaecological Oncology at the Greater Poland Cancer Centre between January 2012 and October 2014 for radiotherapy planning. Each patient underwent physical and ultrasound gynaecological examination with an abdominal and vaginal probe. Additionally, magnetic resonance imaging (MRI) was performed to determine the stage of disease and for radiotherapy planning. A ^18^F-FDG-PET/CT examination was performed in the Nuclear Medicine Department in Greater Poland Cancer Centre on a Gemini TF 16 PET/CT scanner prior to treatment, within a month of diagnosis. The procedure was performed in patients who were fasting for at least five hours before the test (mean glucose level was 93 ±18 mg/dl) in order to avoid problems with the interpretation of the study. The patients after the administration of the isotope stayed in a darkened room at room temperature to rest without any excessive physical activity. Acquisition was performed an average of 60 min after intravenous injection of 374 ±75 MBq of ^18^F-FDG. The study protocol extended from the calvaria to the mid-thigh and included 10--12 bed positions, with 1.5 min per bed position and cutting scans 5 mm thick. The study began with the implementation of simultaneous, low-dose computed tomography (CT), beginning in the brain area, through the chest, abdominal cavity, and pelvis to better visualise the areas with increased uptake and to correct attenuation. Afterwards, the PET acquisition was performed without changing the patient's position. Reconstructions were performed at an EBW workstation using the time-of-flight (TOF) technique.

As a result of the PET/CT analysis, areas with increased metabolism considered as active tumour foci were indicated. The primary tumour metabolic activity was assessed by SUV~max~ and SUV~mean~, and calculated from the formula:

SUV

=

r

a

/

w

where *r* is the radioactivity concentration (kBq/ml) measured by the PET scanner within a region of interest (ROI), *a* is the decay-corrected amount of injected ^18^F-FDG (MBq), and *w* is the patient's weight (kg).

Metabolic volumes of the primary tumour were calculated using three segmentation methods based on:

-   SUV~max~ value (2.5),

-   threshold of SUV~max~ 35% (Th 35%),

-   threshold of SUV~max~ 45% (Th 45%).

The volumes taken from ^18^F-FDG-PET/CT examination were compared with the volumes obtained in MRI, which was treated as a "gold standard" because it is the most precise imaging method for the assessment of the primary tumour volume in cervical cancer \[[@cit0008]\], to select the optimal segmentation method in PET. Volume measurements were calculated automatically in dedicated workstations in the Nuclear Medicine and Radiology Department, without user modifications.

Normality of the data distribution was assessed using Kolmogorov-Smirnov test or *W* Shapiro-Wilk test. For statistical analysis the Wilcoxon-Mann-Whitney and *t*-test were used. Pearson coefficients were used to estimate correlation between parameters. All statistical analysis was performed in the extended STATISTICA application version 13.1 with a medical package, created by StatSoft Polska 2014, as well as the extended Microsoft Excel 2013 application with the Analyse-it package. The mean values of SUV~max~, SUV~mean~, and MTV parameters were evaluated using three segmentation methods. The value of *p* \< 0.05 was considered statistically significant.

Results {#sec3}
=======

The results of the PET/CT study divided the 30 patients into three subgroups: A -- disease limited only to the cervix (33%), B -- disease limited to the cervix and iliac lymph nodes (37%), C -- disseminated disease to the lymph nodes above aorta bifurcation or other organs (30%). In all analyzed groups non-keratinizing squamous cell carcinoma (SCC) was diagnosed.

The analysis of the results performed in the whole group of patients, using different segmentation methods, showed significant differences (*p* \< 0.001) in the mean volumes -- the largest tumour volumes were obtained using the method based on SUV~max~ 2.5 (MTV = 65.47 cm^3^), and the smallest with the method based on threshold of SUV ~max~ 45% (MTV = 33.68 cm^3^), as shown in [Figure 1](#f0001){ref-type="fig"}. Different tumour volumes also resulted in a differentiation in metabolic activity parameters measured by SUV~mean~ values. Differences in the SUV~mean~ values of the metabolically active tumour, depending on the segmentation method applied, reached 50% ([Fig. 2](#f0002){ref-type="fig"}). Depending on the chosen segmentation method, statistically significant differences (*p* \< 0.001) were demonstrated between SUV~mean~ and MTV values for all three groups ([Table 1](#t0001){ref-type="table"}).

###### 

The influence of different segmentation methods on the evaluated parameters depending on the group

                SUV~max~ 2.5   Th 35%         Th 45%                                                                                    
  ------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- --------------
  SUV~max~      11.7 ±4.9      13.1 ±4.7      11.1 ±4.4      12.1 ±5.1      13.1 ±4.7      11.1 ±4.4      12.5 ±5.6      13.1 ±4.7      11.1 ±4.4
  SUV~mean~     4.8 ± 1.1      5.5 ±1.4       4.8 ±1.3       6.0 ±2.1       6.9 ±2.6       5.7 ±2.6       6.9 ±2.3       7.7 ±2.7       6.4 ±2.8
  MTV (cm^3^)   51.01 ±62.79   68.90 ±62.96   67.28 ±52.85   34.13 ±32.06   44.48 ±35.59   49.60 ±36.22   26.06 ±28.23   33.65 ±28.42   35.47 ±27.85

A -- disease limited to the cervix (33%), B -- disease limited to the cervix and iliac lymph nodes (37%), C -- disseminated disease to the lymph nodes above aorta bifurcation or other organs (30%)

![The effect of different segmentation methods on the volume of primary tumour assessed in the whole group](WO-23-89248-g001){#f0001}

![Average SUV~mean~ values depending on the chosen segmentation method in the whole group](WO-23-89248-g002){#f0002}

In comparison with MRI, the highest correlation (*r* = 0.85, *p* = 0.01) in reading the primary tumour metabolic volumes in PET/CT was achieved using the threshold method of segmentation based on 35% of SUV~max~. In the case of the SUV~max~ 45% threshold and constant value of SUV~max~ 2.5, the correlation was lower (*r* = 0.75, *p* = 0.03 and *r* = 0.46, *p* = 0.07, respectively).

Discussion {#sec4}
==========

Determining the volume of the primary tumour is crucial in radiotherapy planning. Because the ^18^F-FDG-PET/CT examination is based on Warburg's observation of increased glucose consumption in malignant tumours, it is regarded as an effective method of determining the metabolic tumour volume of cancerous tissue \[[@cit0009], [@cit0010]\]. According to Sridhar *et al.*, metabolic volumes assessed by ^18^F-FDG-PET/CT are more reliable for large tumours (≥ 10 ml) than for small tumours (≤ 10 ml) \[[@cit0011]\]. In this study we did not observe such a dependence. The volumes of primary tumours were comparable to those from MRI imaging when a threshold of SUV~max~ 35% method was chosen, regardless of the size of the primary tumour.

Many methods have been proposed for determining tumour volume in the ^18^F-FDG-PET/CT study. One of them is the manual method in which a nuclear medicine specialist defines the border between tumour and normal tissue. This method largely depends on the selection of the right window for CT imaging as well as tumour and surrounding tissue characteristics. It is also dependent on the person evaluating the test, with a variability ranging from 5% to 45% \[[@cit0011], [@cit0012]\]. Hatt *et al.* analyzed 25 patients with non-small cell lung cancer (NSCLC) and compared the volumes obtained with CT and PET. They showed that volumes obtained with CT (55 ±74 cm^3^) were significantly higher (*p* \< 0.0001) than those assessed in the PET study (ranging from 18 ±25 to 47 ±76 cm^3^, depending on the chosen delineation method) \[[@cit0013]\]. The method based on 50% threshold cut-off point proposed by Wu *et al.* led to the greatest underestimation of MTV, with errors up to +1.8 cm (+32%) \[[@cit0014]\]. Some authors have reported underestimation of tumour volumes assessed by SUV-based segmentation methods, especially in the case of small tumours, which is of particular importance when determining the size of lymph nodes or small primary lesions \[[@cit0015]\]. Our study showed the largest volumes in the segmentation method based on SUV~max~ 2.5 values in all three groups of patients, which did not correlate with the volumes assessed by MRI. Currently, the threshold adaptive method is one of the most commonly used segmentation methods, among others in head and neck, lung, and cervical cancers \[[@cit0011]\].

Many authors suggest that MTV evaluated by ^18^F-FDG-PET/CT study is a predictor of the patient's outcome in solid tumours. Romesser *et al.* compared SUV~max~, gross tumour volume (GTV) and MTV for disease control and survival in patients with head and neck squamous cell carcinoma (HNSCC) \[[@cit0016]\]. Using the Kaplan-Meier method they concluded that MTV and GTV are better prognostics factors than SUV~max~ for the prediction of local control and overall survival in HNSCC \[[@cit0016]\]. In addition, metabolic tumour volume has been shown to be a better prognostic parameter than SUV~max~ itself in predicting patients' outcome, and it may become useful in clinical evaluation \[[@cit0017]--[@cit0019]\]. Miller and Grigsby noticed that the primary tumour volume determined using ^18^F-FDG-PET affects both the overall survival (*p* = 0.003) and the time to detect the disease spread (*p* = 0.005) in patients with advanced cervical cancer \[[@cit0020]\].

Xu *et al.*, in their analysis of 55 patients with planoepithelial cervical cancer, assessed the effect of different segmentation methods on the metabolic volumes obtained in the ^18^F-FDG-PET/CT study in relation to the size of the tumour obtained from the pathologist \[[@cit0007]\]. Depending on the SUV~max~ value, patients were divided into four subgroups, in which statistically significant differences were observed depending on the choice of the segmentation method (*p* \< 0.005). Metabolic volumes assessed based on 20% and 30% thresholds overvalued, while the threshold 40%, 50%, and 60% undervalued the results, in comparison with GTV assessed in pathological examination performed after radical hysterectomy. The most reliable results were obtained using the iterative adaptive segmentation algorithm \[[@cit0007]\]. Kim *et al.* compared MTV at threshold 40% in 45 patients with invasive cervical cancer with pathological and prognostic results \[[@cit0021]\]. The results showed that patients with MTV greater than 20 cm^3^ had a reduced disease-free survival time compared to those with MTV below 20 cm^3^ (*p* = 0.029). Similar studies conducted by Ciernik *et al.* evaluated the use of PET/CT in the planning of radiotherapy, and 50% SUV~max~ turned out to be a reliable reflection with the tumour volume assessed in the CT technique \[[@cit0022]\]. Showalter *et al.* applied a 40% threshold of SUV~max~ to define the primary tumour diameter in the early stage of cervical cancer and found a significant positive correlation with the tumour diameter assessed by the pathologist (*r* = 0.757, *p* \< 0.0001) \[[@cit0023]\].

This study has a few limitations. The main one is the small number of patients. Secondly,^18^F-FDG-PET/CT cannot precisely assess the severity of the primary tumour local infiltration, due to high physiological activity of the bladder and rectum. Also, physiological ^18^F-FDG uptake is shown, e.g. in urinary tract, ovaries, and uterus during various phases of menstruation, which can mask the malignant lesions. False negative results might be gained in the case of small lesions (\< 7 mm) or different tumour subtypes (e.g. neuroendocrine tumour). False positive results could potentially be obtained in the case of inflammatory or infectious processes \[[@cit0024], [@cit0025]\]. MRI has limited value in the differentiation of metastatic lymph nodes from hyperplasia, in detecting microinvasion in nonenlarged lymph nodes, and for the evaluation of cervical stroma \[[@cit0026], [@cit0027]\]. The limitation in the evaluation of primary tumour size in MRI also includes the impossibility of margin definition, confusing with peritumoral reactions or scars and small tumours (\< 1 cm), which might be only visualised on early dynamic contrast-enhanced sequence (DCE) MRI as enhanced foci \[[@cit0028], [@cit0029]\].

Conclusions {#sec5}
===========

In patients with cervical cancer the choice of appropriate segmentation method of primary tumour in ^18^F-FDG-PET/CT has a significant impact on radiotherapy planning. The metabolic tumour volumes obtained in ^18^F-FDG-PET/CT correlated best with MRI volumes when a threshold of 35% of the SUV~max~ value was chosen as a segmentation method.
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